Soligenix Inc.
SNGX | NASDAQ
$0.50
$0.00 (+0.02%)
Nov 2, 2026, 1:39 PM ET · Market open
+0.02%
(1D)No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Market Cap $5.15M
1D Range
0.46 0.62
52W Range
0.28 6.23
Valuation (TTM)
PE -0.25
PB 1.67
EV/EBITDA 0.05
Valuation (NTM)
Forward PE N/A
Forward PEG N/A
Price Target N/A
Cash Flow
FCF Yield -209.2%
SBC Adj. FCF Yield -219.3%
SBC Impact -4.9%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -33.3% |
-20.0%
Dil EPS 3Y | 5Y 32.4% |
19.7%
FCF 3Y | 5Y 6.3% |
2.1%
Returns
ROA -158.2%
ROE -246.0%
ROIC -327.0%
Financial Health
Net Cash
$5.7M
Current Ratio 1.81
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioThe...
Sector Healthcare
Industry Biotechnology
Employees 14
IPO Date Apr 4, 1994
Website www.soligenix.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove SNGX